Adding dapagliflozin (dapa) to the endothelin A receptor antagonist zibotentan (zibo) did not reduce hepatic venous pressure gradient (HVPG) or fluid retention in patients with compensated or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results